Cost-effectiveness and sustainability of fungal factories for pharmaceutical protein production

There is a large-scale demand for better and more affordable medicines. In this context, acceleration in the development of biopharmaceuticals from conceptualization to market stage in collaboration with the pharmaceutical industry can lead to innovative and low-cost solutions to reduce the financial burden of global healthcare. Technoeconomic (TEA) and life-cycle (LCA) assessments help guide technology development and improvement targets, inform comparative pathway decisions, evaluate policy feasibility, and provide policy guidance through early identification and mitigation of financial or technical challenges.